ID   MMP24_RAT               Reviewed;         618 AA.
AC   Q99PW6;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   24-JAN-2024, entry version 147.
DE   RecName: Full=Matrix metalloproteinase-24;
DE            Short=MMP-24;
DE            EC=3.4.24.-;
DE   AltName: Full=Membrane-type matrix metalloproteinase 5;
DE            Short=MT-MMP 5;
DE            Short=MTMMP5;
DE   AltName: Full=Membrane-type-5 matrix metalloproteinase;
DE            Short=MT5-MMP;
DE            Short=MT5MMP;
DE   Contains:
DE     RecName: Full=Processed matrix metalloproteinase-24;
DE   Flags: Precursor;
GN   Name=Mmp24; Synonyms=Mt5mmp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Sekine-Aizawa Y.;
RT   "Molecular cloning and characterization of rat MT5-MMP.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=10727639; DOI=10.1016/s0006-8993(00)02035-7;
RA   Jaworski D.M.;
RT   "Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-
RT   MMP) expression in the rat nervous system.";
RL   Brain Res. 860:174-177(2000).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, INTERACTION WITH
RP   GRIP1 AND GRIP2, AND MUTAGENESIS OF 616-GLU--VAL-618.
RX   PubMed=16495457; DOI=10.1523/jneurosci.3521-05.2006;
RA   Monea S., Jordan B.A., Srivastava S., DeSouza S., Ziff E.B.;
RT   "Membrane localization of membrane type 5 matrix metalloproteinase by AMPA
RT   receptor binding protein and cleavage of cadherins.";
RL   J. Neurosci. 26:2300-2312(2006).
CC   -!- FUNCTION: Metalloprotease that mediates cleavage of N-cadherin (CDH2)
CC       and acts as a regulator of neuro-immune interactions and neural stem
CC       cell quiescence. Involved in cell-cell interactions between nociceptive
CC       neurites and mast cells, possibly by mediating cleavage of CDH2,
CC       thereby acting as a mediator of peripheral thermal nociception and
CC       inflammatory hyperalgesia. Key regulator of neural stem cells
CC       quiescence by mediating cleavage of CDH2, affecting CDH2-mediated
CC       anchorage of neural stem cells to ependymocytes in the adult
CC       subependymal zone, leading to modulate their quiescence. May play a
CC       role in axonal growth. Able to activate progelatinase A. May also be a
CC       proteoglycanase involved in degradation of proteoglycans, such as
CC       dermatan sulfate and chondroitin sulfate proteoglycans. Cleaves
CC       partially fibronectin, but not collagen type I, nor laminin.
CC       {ECO:0000269|PubMed:16495457}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts (via PDZ-binding motif) with APBA3 (via PDZ domain)
CC       (By similarity). Interacts with GRIP1 and GRIP2. {ECO:0000250,
CC       ECO:0000269|PubMed:16495457}.
CC   -!- SUBCELLULAR LOCATION: [Matrix metalloproteinase-24]: Cell membrane;
CC       Single-pass type I membrane protein. Golgi apparatus, trans-Golgi
CC       network membrane {ECO:0000250}; Single-pass type I membrane protein
CC       {ECO:0000250}. Note=Recycled back to the plasma membrane through the
CC       trans-Golgi network via interaction with APBA3. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Processed matrix metalloproteinase-24]:
CC       Secreted, extracellular space, extracellular matrix {ECO:0000250}.
CC       Note=Also shed from cell surface as soluble proteinase, by a
CC       proteolytic cleavage. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the nervous system:
CC       while enriched in the central nervous system, expression is also
CC       detected in the peripheral nervous system, including the trigeminal
CC       ganglion. Expression is not restricted to the nervous system: it is
CC       also enriched in the thymus, with a lower level of expression present
CC       in the aorta. In brain, high expression is present in the brain
CC       parenchyma, particularly within the neocortex.
CC       {ECO:0000269|PubMed:10727639}.
CC   -!- DEVELOPMENTAL STAGE: Expression is first detected in embryonic day 16
CC       (16 dpc) brain, strongly increases at 20 dpc, and peaks within 24 hours
CC       of birth. The postnatal expression declines steadily to reach adult
CC       levels at P60. {ECO:0000269|PubMed:10727639}.
CC   -!- DOMAIN: The PDZ-binding motif (also named EWV motif) is required for
CC       interaction with PDZ domains of APBA3 and recycling through the trans-
CC       Golgi network. {ECO:0000269|PubMed:16495457}.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch motif
CC       binds the catalytic zinc ion, thus inhibiting the enzyme. The
CC       dissociation of the cysteine from the zinc ion upon the activation-
CC       peptide release activates the enzyme.
CC   -!- PTM: Cleaved by a furin endopeptidase in the trans-Golgi network.
CC   -!- SIMILARITY: Belongs to the peptidase M10A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB023659; BAB32589.1; -; mRNA.
DR   RefSeq; NP_113945.1; NM_031757.1.
DR   AlphaFoldDB; Q99PW6; -.
DR   SMR; Q99PW6; -.
DR   STRING; 10116.ENSRNOP00000075211; -.
DR   MEROPS; M10.023; -.
DR   PhosphoSitePlus; Q99PW6; -.
DR   PaxDb; 10116-ENSRNOP00000067398; -.
DR   Ensembl; ENSRNOT00000092194.2; ENSRNOP00000075211.2; ENSRNOG00000047028.3.
DR   Ensembl; ENSRNOT00055042228; ENSRNOP00055034461; ENSRNOG00055024534.
DR   Ensembl; ENSRNOT00060049130; ENSRNOP00060041008; ENSRNOG00060028218.
DR   Ensembl; ENSRNOT00065048964; ENSRNOP00065040152; ENSRNOG00065028413.
DR   GeneID; 83513; -.
DR   KEGG; rno:83513; -.
DR   AGR; RGD:620202; -.
DR   CTD; 10893; -.
DR   RGD; 620202; Mmp24.
DR   eggNOG; KOG1565; Eukaryota.
DR   GeneTree; ENSGT00940000158315; -.
DR   InParanoid; Q99PW6; -.
DR   OMA; AMTQHYY; -.
DR   OrthoDB; 2225278at2759; -.
DR   PhylomeDB; Q99PW6; -.
DR   Reactome; R-RNO-1592389; Activation of Matrix Metalloproteinases.
DR   PRO; PR:Q99PW6; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   GO; GO:0031012; C:extracellular matrix; IEA:InterPro.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0032588; C:trans-Golgi network membrane; ISS:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; ISO:RGD.
DR   GO; GO:0004222; F:metalloendopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; TAS:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; ISS:UniProtKB.
DR   GO; GO:0098742; P:cell-cell adhesion via plasma-membrane adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0030574; P:collagen catabolic process; IBA:GO_Central.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0010001; P:glial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; ISS:UniProtKB.
DR   CDD; cd00094; HX; 1.
DR   CDD; cd04278; ZnMc_MMP; 1.
DR   Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1.
DR   Gene3D; 2.110.10.10; Hemopexin-like domain; 1.
DR   InterPro; IPR000585; Hemopexin-like_dom.
DR   InterPro; IPR036375; Hemopexin-like_dom_sf.
DR   InterPro; IPR018487; Hemopexin-like_repeat.
DR   InterPro; IPR018486; Hemopexin_CS.
DR   InterPro; IPR033739; M10A_MMP.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001818; Pept_M10_metallopeptidase.
DR   InterPro; IPR021190; Pept_M10A.
DR   InterPro; IPR021805; Pept_M10A_metallopeptidase_C.
DR   InterPro; IPR006026; Peptidase_Metallo.
DR   InterPro; IPR002477; Peptidoglycan-bd-like.
DR   InterPro; IPR036365; PGBD-like_sf.
DR   PANTHER; PTHR10201; MATRIX METALLOPROTEINASE; 1.
DR   PANTHER; PTHR10201:SF138; MATRIX METALLOPROTEINASE-24; 1.
DR   Pfam; PF11857; DUF3377; 1.
DR   Pfam; PF00045; Hemopexin; 4.
DR   Pfam; PF00413; Peptidase_M10; 1.
DR   Pfam; PF01471; PG_binding_1; 1.
DR   PIRSF; PIRSF001191; Peptidase_M10A_matrix; 1.
DR   PRINTS; PR00138; MATRIXIN.
DR   SMART; SM00120; HX; 4.
DR   SMART; SM00235; ZnMc; 1.
DR   SUPFAM; SSF50923; Hemopexin-like domain; 1.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
DR   SUPFAM; SSF47090; PGBD-like; 1.
DR   PROSITE; PS00024; HEMOPEXIN; 1.
DR   PROSITE; PS51642; HEMOPEXIN_2; 4.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell membrane; Cleavage on pair of basic residues;
KW   Disulfide bond; Extracellular matrix; Golgi apparatus; Hydrolase; Membrane;
KW   Metal-binding; Metalloprotease; Protease; Reference proteome; Repeat;
KW   Secreted; Signal; Transmembrane; Transmembrane helix; Zinc; Zymogen.
FT   SIGNAL          1..41
FT                   /evidence="ECO:0000255"
FT   PROPEP          42..128
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000028850"
FT   CHAIN           129..618
FT                   /note="Matrix metalloproteinase-24"
FT                   /id="PRO_0000028851"
FT   CHAIN           129..554
FT                   /note="Processed matrix metalloproteinase-24"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000302760"
FT   TOPO_DOM        42..575
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        576..596
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        597..618
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          350..398
FT                   /note="Hemopexin 1"
FT   REPEAT          399..444
FT                   /note="Hemopexin 2"
FT   REPEAT          446..494
FT                   /note="Hemopexin 3"
FT   REPEAT          495..542
FT                   /note="Hemopexin 4"
FT   REGION          296..352
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           110..117
FT                   /note="Cysteine switch"
FT                   /evidence="ECO:0000250"
FT   MOTIF           616..618
FT                   /note="PDZ-binding"
FT   COMPBIAS        320..336
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        256
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         112
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /note="in inhibited form"
FT                   /evidence="ECO:0000250"
FT   BINDING         255
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         259
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         265
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   SITE            554..555
FT                   /note="Cleavage; by furin"
FT                   /evidence="ECO:0000250"
FT   DISULFID        353..542
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         616..618
FT                   /note="Missing: Impaired interaction with GRIP1 and GRIP2."
FT                   /evidence="ECO:0000269|PubMed:16495457"
SQ   SEQUENCE   618 AA;  70465 MW;  614ED4EEC6B27F5F CRC64;
     MPRSRGGRAA PGQAARWSGW RAPGRLLPLL PALCCLAAAA GAGKPAGADA PFAGQNWLKS
     YGYLLPYESR ASALHSGKAL QSAVSTMQQF YGIPVTGVLD QTTIEWMKKP RCGVPDHPHL
     SRRRRNKRYA LTGQKWRQKH ITYSIHNYTP KVGELDTRKA IRQAFDVWQK VTPLTFEEVP
     YHEIKSDRKE ADIMIFFASG FHGDSSPFDG EGGFLAHAYF PGPGIGGDTH FDSDEPWTLG
     NANHDGNDLF LVAVHELGHA LGLEHSNDPS AIMAPFYQYM ETHNFKLPQD DLQGIQKIYG
     PPAEPLEPTR PLPTLPVRRI HSPSERKHER QPRPPRPPLG DRPSTPGAKP NICDGNFNTV
     ALFRGEMFVF KDRWFWRLRN NRVQEGYPMQ IEQFWKGLPA RIDAAYERAD GRFVFFKGDK
     YWVFKEVTVE PGYPHSLGEL GSCLPREGID TALRWEPVGK TYFFKGERYW RYSEERRATD
     PGYPKPITVW KGIPQAPQGA FISKEGYYTY FYKGRDYWKF DNQKLSVEPG YPRNILRDWM
     GCKQKEVERR KERRLPQDDV DIMVTIDDVP GSVNAVAVVV PCTLSLCLLV LLYTIFQFKN
     KTGPQPVTYY KRPVQEWV
//
